Early-onset, extreme obesity due to biologically inactive leptin is a new disease entity characterized by high immunoreactive levels of circulating leptin, but a reduced bioactivity of the hormone caused e.g. by defects in receptor binding. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.